Von Willebrand Factor

RESEARCH TRIANGLE, North Carolina — August 25, 2026 Basking Biosciences announced positive topline Phase 1 data for BB-025, an...

RESEARCH TRIANGLE, N.C., July 30, 2026 Basking Biosciences has announced the publication of groundbreaking preclinical research in Communications Biology,...

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, July 12, 2026 Hemab Therapeutics announced encouraging new clinical findings from its HMB-002 program...

PARAMUS, N.J. | July 8, 2026 Octapharma USA has announced that the U.S. Food and Drug Administration (FDA) has...